These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15305158)

  • 21. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
    Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
    Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
    Egger ME; Huber KM; Dunki-Jacobs EM; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM; Callender GG
    J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy for cutaneous melanoma: a propos of 144 cases.
    Konofaos P; Karypidis D; Chrisostomidis C; Kostopoulos E; Champsas G; Papadopoulos O
    J BUON; 2014; 19(1):263-72. PubMed ID: 24659674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
    Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
    Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
    Woods JF; De Marchi JA; Lowery AJ; Hill AD
    Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transected thin melanoma: Implications for sentinel lymph node staging.
    Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
    J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to Procedure, Nuclear Imaging and Clinicopathological Characteristics as Predictive Factors for Sentinel Lymph Node Metastasis in Cutaneous Melanoma: A Single-Center Analysis.
    Jaukovic L; Rajović M; Kandolf Sekulovic L; Radulovic M; Stepic N; Mijuskovic Z; Petrov N; Ajdinovic B
    Ann Plast Surg; 2018 Jul; 81(1):80-86. PubMed ID: 29762449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.
    Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Fraile M; Alastrué A; Ferrándiz C
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1385-93. PubMed ID: 16416605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of sentinel lymph node status and onset of regional lymph nodes metastases in melanoma.
    Noveski L; Dzokic G; Dzonov B; Zafirova-Ivanovska B; Zhivadinovik J
    Prilozi; 2012; 33(2):131-40. PubMed ID: 23425876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
    Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
    J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
    Namikawa K; Aung PP; Gershenwald JE; Milton DR; Prieto VG
    Cancer Med; 2018 Mar; 7(3):583-593. PubMed ID: 29464914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of early recurrence after sentinel lymph node biopsy for melanoma.
    Chao C; Wong SL; Ross MI; Reintgen DS; Noyes RD; Cerrito PB; Edwards MJ; McMasters KM;
    Am J Surg; 2002 Dec; 184(6):520-4; discussion 525. PubMed ID: 12488154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma.
    McMasters KM; Wong SL; Edwards MJ; Ross MI; Chao C; Noyes RD; Viar V; Cerrito PB; Reintgen DS
    Surgery; 2001 Aug; 130(2):151-6. PubMed ID: 11490343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
    Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
    Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm).
    Holmberg CJ; Mikiver R; Isaksson K; Ingvar C; Moncrieff M; Nielsen K; Ny L; Lyth J; Olofsson Bagge R
    Ann Surg Oncol; 2023 Dec; 30(13):8026-8033. PubMed ID: 37574516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.